[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3,6-dioxo-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetateNorethisterone Acetate EP Impurity GNorethisterone acetate impurity G [EP](8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3,6-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate6-Ketonorethindrone Acetate3,6-Dioxo-19-nor-17alpha-pregn-4-en-20-yn-17-yl Acetate (6-Ketonorethisterone Acetate)Norethisterone Acetate Imp. G (EP); 3,6-Dioxo-19-nor-17alpha-pregn-4-en-20-yn-17-yl Acetate; 6-Ketonorethisterone Acetate; Norethisterone Acetate Impurity GNorethindrone Acetate EP Impurity G
Properties
Computed structural propertiesFilling in
XLogP
2.3
Topological polar surface area
60.4 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
26
Formal charge
0
Complexity
768
Physicochemical properties
Melting point
165 °C · 165 °C - 167 °C
Boiling point
479.8 · 479.8±45.0 °C(Predicted)
Density
1.2 · 1.20±0.1 g/cm3(Predicted)
storage temp.
Refrigerator
solubility
Chloroform (Slightly)
form
Solid
color
Light Yellow
FDA UNII
7 SN766M6T · W7SN766M6T
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
GHS classification
GHS Classification · 4 items
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P233, P260, P264, P270, P271, P284, P301+P317, P304+P340, P330, P342+P316, P403, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Chemistry & industry
Applications
Uses6-Oxo Norethindrone Acetate (Norethindrone Acetate EP Impurity G) is an oxidative product of Norethindrone acetate (N675990).